Profil
Elisabeth M.
M.
Gardiner worked as a Director-Physiology Discovery at aTyr Pharma, Inc. and as a Principal at Kalypsys, Inc. She was also a Vice President-Discovery Biology at Kinnate Biopharma, Inc. from 2018 to 2020.
Gardiner served as VP-Translational Medicine & Patrick Simms at Aravive, Inc. from 2020 to 2022.
She holds a doctorate degree from the University of Wisconsin.
Anciens postes connus de Elisabeth M. M. Gardiner
| Sociétés | Poste | Fin |
|---|---|---|
| ARAVIVE, INC. | Corporate Officer/Principal | 01/04/2022 |
| KINNATE BIOPHARMA INC. | Corporate Officer/Principal | 01/06/2020 |
Kalypsys, Inc.
Kalypsys, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel, first-in-class therapeutic agents to address unmet medical needs in respiratory and inflammatory diseases | Corporate Officer/Principal | - |
| ATYR PHARMA, INC. | Corporate Officer/Principal | - |
Formation de Elisabeth M. M. Gardiner
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Kalypsys, Inc.
Kalypsys, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel, first-in-class therapeutic agents to address unmet medical needs in respiratory and inflammatory diseases | Health Technology |
aTyr Pharma, Inc.
aTyr Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a bio therapeutics company that discovers and develops medicines based on novel biological pathways | Health Technology |
University of Wisconsin
University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aravive, Inc.
Aravive, Inc. BiotechnologyHealth Technology Develops therapies for solid tumors and hematologic malignancies | Health Technology |
Kinnate Biopharma, Inc.
Kinnate Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage precision oncology company | Health Technology |
















